TScan Therapeutics, Inc. (TCRX)

TScan Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	169.51	178.69	133.36	120.03	161.41	34.79
Short-Term Investments	14.95	111.42	58.69	-	-	-
Cash & Short-Term Investments	184.45	290.11	192.04	120.03	161.41	34.79
Cash Growth	-31.97%	51.06%	60.00%	-25.64%	363.93%	-16.70%
Prepaid Expenses	3.71	2.61	2.19	4.1	4.25	1.65
Total Current Assets	188.17	292.72	194.24	124.13	165.65	36.45
Property, Plant & Equipment	68.74	71.6	71.23	69.2	17.26	12.53
Other Long-Term Assets	5.32	6.8	6.68	5.76	5.2	0.76
Total Assets	262.23	371.12	272.15	199.09	188.11	49.74
Accounts Payable	6.35	4.28	2.37	2.91	1.77	2.91
Accrued Expenses	10.58	15.33	10.29	6.41	5.51	2.36
Current Portion of Long-Term Debt	-	-	3.35	-	-	-
Current Portion of Leases	6.9	4.57	3.25	3.68	1.65	1.42
Current Unearned Revenue	5.19	11.7	10.14	3.87	11.41	10.63
Other Current Liabilities	0.19	0.08	0.43	0.43	1.01	0.13
Total Current Liabilities	29.21	35.96	29.82	17.31	21.34	17.45
Long-Term Debt	32.41	32.07	26.7	29.29	-	-
Long-Term Leases	56.3	60.74	59.14	53.01	4.39	6.02
Long-Term Unearned Revenue	-	1.25	5.62	-	1.5	8.82
Other Long-Term Liabilities	0.28	0.14	-	0.05	0.1	0.24
Total Liabilities	118.2	130.15	121.28	99.66	27.33	32.52
Common Stock	0.01	0.01	0.01	0	0	0
Additional Paid-In Capital	625.9	616.01	398.46	257.81	252.93	1.07
Retained Earnings	-481.89	-375.1	-247.6	-158.38	-92.16	-43.53
Comprehensive Income & Other	0	0.05	-	-	-	-
Total Common Equity	144.02	240.97	150.87	99.43	160.78	-42.46
Shareholders' Equity	144.02	240.97	150.87	99.43	160.78	17.22
Total Liabilities & Equity	262.23	371.12	272.15	199.09	188.11	49.74
Total Debt	95.62	97.38	92.43	85.98	6.04	7.43
Net Cash (Debt)	88.83	192.73	99.61	34.04	155.36	27.36
Net Cash Growth	-50.86%	93.48%	192.60%	-78.09%	467.91%	-25.82%
Net Cash Per Share	1.57	3.41	2.08	1.42	13.32	29.87
Filing Date Shares Outstanding	56.75	56.59	47.88	24.23	23.86	1.14
Total Common Shares Outstanding	56.75	56.59	47.83	24.23	23.91	1.14
Working Capital	158.96	256.77	164.42	106.82	144.31	19
Book Value Per Share	2.54	4.26	3.15	4.10	6.72	-37.38
Tangible Book Value	144.02	240.97	150.87	99.43	160.78	-42.46
Tangible Book Value Per Share	2.54	4.26	3.15	4.10	6.72	-37.38
Machinery	-	22.59	18.63	16.87	12.15	6.14
Construction In Progress	-	0.1	0.55	0.01	1.26	0.78
Leasehold Improvements	-	3.26	3.16	3.45	3.43	0.49

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q